Epstein-Barr virus associated CNS lymphoproliferative disorder after long-term immunosuppression.
Pract Neurol
; 20(1): 83-86, 2020 Feb.
Article
en En
| MEDLINE
| ID: mdl-31467148
ABSTRACT
The incidence of Epstein-Barr virus (EBV)associated lymphoproliferative disorders has increased with greater use of immunomodulatory therapies. We present a woman who developed subacute cognitive decline and unilateral weakness while taking long-term mycophenolate mofetil for granulomatosis with polyangiitis; her postmortem brain histopathology confirmed an EBV-driven lymphoproliferative disorder. Clinicians must have a high index of suspicion for EBV-driven lymphoma in people taking long-term immunosuppression who develop new neurological problems. We review the role of mycophenolate mofetil in EBV-driven lymphoproliferative disorders, and discuss checking EBV status in all patients starting immunosuppression and in older people already taking immunosuppression.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hemorragia Cerebral
/
Terapia de Inmunosupresión
/
Infecciones por Virus de Epstein-Barr
/
Inmunosupresores
/
Trastornos Linfoproliferativos
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
Pract Neurol
Año:
2020
Tipo del documento:
Article
País de afiliación:
Reino Unido